NCT02210858 2018-06-04Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative DisordersNational Cancer Institute (NCI)Phase 1/2 Completed31 enrolled
NCT00005967 2013-02-11Tipifarnib in Treating Patients With Advanced Hematologic CancerNational Cancer Institute (NCI)Phase 1 Completed36 enrolled